Sipuleucel-T Pregnancy and Breastfeeding Warnings
Brand names: Provenge
Medically reviewed by Drugs.com. Last updated on Dec 24, 2024.
Sipuleucel-T Pregnancy Warnings
The manufacturer makes no recommendation regarding use during pregnancy; this drug is not indicated for use in female patients.
US FDA pregnancy category: Not Assigned
Comments: The manufacturer product information indicates studies on the effects of fertility have not been conducted.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.
Sipuleucel-T Breastfeeding Warnings
The manufacturer makes no recommendation regarding use during lactation; this drug is not indicated for use in female patients.
Excreted into human milk: Unknown
Excreted into animal milk: Unknown
See also
References for pregnancy information
- (2022) "Product Information. Provenge (sipuleucel-T)." Dendreon Corporation
References for breastfeeding information
- (2022) "Product Information. Provenge (sipuleucel-T)." Dendreon Corporation
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.